Griffith Hsu, MD
Otology & Neurotology · Glen Ellyn, ILNPI 1669448056
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (31.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Cook Medical LLC at 47.1% of the total. Reporting peaked in 2022 at $3,126 and has fallen 79.0% since, to $658 in 2024.
Across 29 payments — averaging $220.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Medical LLC$3K
- Intersect ENT, Inc.$2K
- Aerin Medical Inc.$266
- GSK$222
- Neurent Medical Limited$169
- Regeneron Healthcare Solutions, Inc.$122
- plus $356 from 6 others
What the payments were for
- Consulting fees$1,29020%
- Speaking & faculty fees$1,72027%
- Travel & lodging$1,36421%
- Food & beverage$2,01432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Medical LLC | 3 | $3,010 |
| Intersect ENT, Inc. | 12 | $2,244 |
| Aerin Medical Inc. | 4 | $266 |
| GSK | 2 | $222 |
| Neurent Medical Limited | 1 | $169 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Optinose US, Inc. | 1 | $115 |
| Cochlear Americas | 1 | $94 |
| Acclarent, Inc | 1 | $78 |
| Stryker | 1 | $28 |
| Smith+Nephew | 1 | $23 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIODESIGN$3,010
- PROPEL$2,003
- SINUVA$1,701
- NUCALA$222
- NEUROMARK Device$169
- NEUROMARK Radiofrequency Console$169
- VIVAER STYLUS$132
- RHINAER STYLUS$132
- DUPIXENT$122
- Xhance$115
How this compares
Too few otology & neurotology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 13 | $833 |
| Ipratropium Bromide | 16 | $207 |
| Montelukast Sodium | 14 | $138 |
| Omeprazole | 25 | $137 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Glen Ellyn
- Elias MichaelidesChicago$23K
- Kevin ZhanChicago$19K
- Sam MarzoMaywood$5K
- Terence ImberyChicago$4K
- Alan MiccoChicago$3K
- Richard WietWinfield$3K
- Dennis MoorePark Ridge$2K
- John LeonettiMaywood$1K
- Robin RiceChicago$705
- Rishi ZaveriElmhurst$374
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.